HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study

Clinical trial NCT05720767 · COMPLETED

Trial details

NCT number: NCT05720767
Sponsor: Hutchmed
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Lymphoma

Start date: 2022-11-04
Primary completion: 2023-02-05
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.